HMSN II (CMT2) and Miscellaneous Inherited System Atrophies of Nerve Axon: Clinical-Molecular Genetic Correlates

Peripheral Neuropathy

Volumn 2, Issue , 2005, Pages 1717-1751

  Klein, Christopher J ^a   Dyck, Peter J ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 14244265932     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-9491-7.50076-4     Document Type: Chapter

References (227)

1. Abrams C.K., Oh S., Ri Y., Bargiello T.A. Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 2000, 32:203.
2. Aicardi J., Castelein P. Infantile neuroaxonal dystrophy. Brain 1979, 102:727.
3. Alexander C., Votruba M., Pesch U.E., et al. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26:211.
4. Alper G., Narayanan V. Friedreich's ataxia. Pediatr. Neurol. 2003, 28:335.
5. Ammar N., Nelis E., Merlini G. Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease. Neuromuscul. Disord. 2003, 13:720.
6. Andermann E., Andermann F., Bergeron D., et al. Familial agenesis of the corpus callosum with sensorimotor neuronopathy. J. Neurol. Sci. 1979, 6:400.
7. Antonellis A., Ellsworth R.E., Sambuughin N., et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet. 2003, 72:1293.
8. Antonini G., Gragnani F., Romaniello A., et al. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease). Muscle Nerve 2000, 23:252.
9. Aragane N., Katoh O., Yamada H., et al. Respiratory failure due to vocal cord dyskinesia in olivo-ponto-cerebellar atrophy. Chest 1989, 96:1212.
10. Arroyo E.J., Scherer S.S. On the molecular architecture of myelinated fibers. Histochem. Cell Biol. 2000, 113:1.
11. Asbury A.K. Giant axonal neuropathy-a unique case with segmental neurofilamentous masses. Acta Neuropathol. (Berl.) 1972, 20:237.
12. Auer-Grumbach M., De Jonghe P., Verhoeven K., et al. Autosomal dominant inherited neuropathies with prominent sensory loss and mutilations: a review. Arch. Neurol. 2003, 60:329.
13. Auer-Grumbach M., De Jonghe P., Wagner K., et al. Phenotype-genotype correlations in a CMT2B family with refined 3q13-q22 locus. Neurology 2000, 55:1552.
14. Azzedine H., Ruberg M., Ente D., et al. Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene. Neuromuscul. Disord. 2003, 13:341.
15. Baker R.S., Upton A.R.M. Variations on a phenotype in Charcot-Marie-Tooth disease. Neuropaediatrie 1979, 10:290.
16. Barbieri F., Pellecchia M.T., Esposito E., et al. Adult-onset familial laryngeal abductor paralysis, cerebellar ataxia, and pure motor neuropathy. Neurology 2001, 56:1412.
17. Baxter R.V., Othmane K., Rochelle J.M., et al. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nat. Genet. 2002, 30:21.
18. Begeer J.H., Houthoff H.J., vanWeerden T.W, et al. Infantile neuroaxonal dystrophy and giant axonal neuropathy: are they related? Ann. Neurol. 1979, 6:540.
19. Bellone E., Cassandrini D., Mari E., et al. Novel MPZ mutation in a sporadic CMT patient. J. Peripher. Nerv. Syst. 2001, 6:41.
20. Ben Hamida C., Cavalier L., Belal S., et al. Homozygosity mapping of giant axonal neuropathy gene to chromosome 16q24.1. Neurogenetics 1997, 1:129.
21. Berard-Badier M., Gambarelli D., Pinsard N., et al. Infantile neuroaxonal dystrophy and giant axonal dystrophy of Seitelberger's disease: II. Peripheral nerve involvement: electron microscopic study in one case. Acta Neuropathol. (Berl.) 1971, 5(Suppl. 5):30.
22. Berg B.O., Rosenberg S.H., Asbury A.K. Giant axonal neuropathy. Pediatrics 1972, 49:894.
23. Bhat M.A., Rios J.C., Lu Y., et al. Axon-glia interactions and the domain organization of myelinated axons require neurexin IV/caspr/paranodin. Neuron 2001, 30:369.
24. Bienfait H.M., Baas F., Gabreels-Festen A.A., et al. Two amino-acid substitutions in the myelin protein zero gene of a case of Charcot-Marie-Tooth disease associated with light-near dissociation. Neuromuscul. Disord. 2002, 12:281.
25. Bird T.D., Ott J., Giblett E.R. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1. Am. J. Hum. Genet. 1982, 34:388.
26. BiroGBR N., Azzedine H., Dubourg O., et al. Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene. Arch. Neurol. 2003, 60:598.
27. BiroGBR N., LeGuern E., Maisonobe T., et al. X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology 1998, 50:1074.
28. Bolino A., Muglia M., Conforti F.L., et al. Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet. 2000, 25:17.
29. Boltshauser E., Bischoff A., Isler W. Giant axonal neuropathy: report of a case with normal hair. J. Neurol. Sci. 1977, 31:269.
30. Bomont P., Cavalier L., Blondeau F., et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat. Genet. 2000, 26:370-374.
31. Bonne G., Barletta M.R., Varnous S., et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat. Genet. 1999, 21:285-288.
32. Bosio A., Binczek E., Stoffel W. Functional breakdown of the lipid bilayer of the myelin membrane in central and peripheral nervous system by disrupted galactocerebroside synthesis. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:13280-13285.
33. Boyle M.E., Berglund E.O., Murai K.K., et al. Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve. Neuron 2001, 30:385.
34. Brown R.A.A. Genetic and molecular basis for neuro-muscular diseases. Neuromuscular Function and Disease 2002, 619. W.B. Saunders, Philadelphia. W.F. Brown, C.F. Bolton, M.J. Aminoff (Eds.).
35. Cantalupo G., Alifano P., Roberti V., et al. Rab-interacting lysosomal protein (RILP): the Rab7 effector required for transport to lysosomes. EMBO J. 2001, 20:683.
36. Carenini S., Maurer M., Werner A., et al. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in p0. J. Cell Biol. 2001, 152:301.
37. Carpenter S. The pathology of Andermann syndrome. Callosal Agenesis: A Natural Split Brain 1994, 27. Plenum, New York. M. Lassonde, M. Jeeves (Eds.).
38. Carpenter S., Karpati G., Andermann F., Gold R. Giant axonal neuropathy: a clinically and morphologically distinct neurological disease. Arch. Neurol. 1974, 31:312.
39. Carroll R.C., Beattie E.C., Xia H., et al. Dynamin-dependent endocytosis of inotropic glutamate receptors. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14112.
40. Casari G., De Fusco M., Ciarmatori S., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998, 93:973.
41. Chalmers R.M., Bird A.C., Harding A.E. Autosomal dominant optic atrophy with asymptomatic peripheral neuropathy. J. Neurol. Neurosurg. Psychiatry 1996, 60:195.
42. Chalmers R.M., Riordan-Eva P., Wood N.W. Autosomal recessive inheritance of hereditary motor and sensory neuropathy with optic atrophy. J. Neurol. Neurosurg. Psychiatry 1997, 62:385.
43. Chaouch M., Allal Y., De Sandre-Giovannoli A., et al. The phenotypic manifestations of autosomal recessive axonal Charcot-Marie-Tooth due to a mutation in lamin A/C gene. Neuromuscul. Disord. 2003, 13:60.
44. Chapon F., Latour P., Diraison P., et al. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene. J. Neurol. Neurosurg. Psychiatry 1999, 66:779.
45. Christodoulou K., Kyriakides T., Hristova A.H., et al. Mapping of a distal form of spinal muscular atrophy with upper limb predominance to chromosome 7p. Hum. Mol. Genet. 1995, 4:1629.
46. Coetzee T., Fujita N., Dupree J., et al. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell 1996, 86:209.
47. Comi G.P., Ciafaloni E., de Silva H.A., et al. A G + 1 A transversion at the 5 splice site of intron 69 of the dystrophin gene causing the absence of peripheral nerve Dp116 and severe clinical involvement in a DMD patient. Hum. Mol. Genet. 1995, 4:2171. [Erratum appears in Hum. Mol. Genet. 5: 562, 1996.].
48. Cowchock F.S., Duckett S.W., Streletz L.J., et al. X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder. Am. J. Med. Genet. 1985, 20:307.
49. Cowen D., Olmstead E.V. Infantile neuroaxonal dystrophy. J. Neuropathol. Exp. Neurol. 1963, 22:175.
50. Cuesta A., Pedrola L., Sevilla T., et al. The gene encoding ganglioside-induced differentiation-associate protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease. Nat. Genet. 2002, 30:22.
51. Cummings C.J., Zoghbi H.Y. Trinucleotide repeats: mechanisms and pathophysiology. Annu. Rev. Genomics Hum. Genet. 2000, 1:281.
52. Dawidenkow A. Uber die neurotische Muskelatrophie Charcot-Marie: Klinish-genetische Studien. Z. Neurol. 1927, 107:259.
53. De Braekeleer M., Dallaire A., Mathieu J. Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec. Hum. Genet. 1993, 91:223.
54. de Jonghe P., Mersivanova I., Nelis E., et al. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E. Ann. Neurol. 2001, 49:245.
55. de Jonghe P., Timmerman V., Ceuterick C., et al. The Thr124Met mutation in the peripheral myelin protein zero (MPZ) gene is associated with a clinically distinct Charcot-Marie-Tooth phenotype. Brain 1999, 122:281.
56. de Jonghe P., Timmerman V., FitzPatrick D., et al. Mutilating neuropathic ulcerations in a chromosome 3q13-q22 linked Charcot-Marie-Tooth disease type 2B family. J. Neurol. Neurosurg. Psychiatry 1997, 62:570.
57. De Michele G., De Fusco M., Cavalcanti F., et al. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am. J. Hum. Genet. 1998, 63:135.
58. De Sandre-Giovannoli A., Chaouch M., Kozlov S., et al. Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am. J. Hum. Genet. 2002, 70:726. [Erratum appears in Am. J. Hum. Genet. 70: 1075, 2002.].
59. DeLong R., Siddique T. A large New England kindred with autosomal dominant neurogenic scapuloperoneal amyotrophy with unique features. Arch. Neurol. 1992, 49:905.
60. Di Donato S., Gellera C., Mariotti C. The complex clinical and genetic classification of inherited ataxias. II. Autosomal recessive ataxias. Neurol. Sci. 2001, 22:219.
61. Donaghy M., Sisodiya S.M., Kennett R., et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J. Neurol. Neurosurg. Psychiatry 2000, 69:799.
62. Duncan C. Peripheral nerve biopsy as an aid to diagnosis in infantile neuroaxonal dystrophy. Neurology 1970, 20:1024.
63. Dupre N., Howard H.C., Mathieu J., et al. Hereditary motor and sensory neuropathy with agenesis of the corpus callosum. Ann. Neurol. 2003, 54:9.
64. Dupree J.L., Girault J.A., Popko B. Axo-glial interactions regulate the localization of axonal paranodal proteins. J. Cell Biol. 1999, 147:1145.
65. Dyck P. Neuronal atrophy and degeneration affecting primary sensory and autonomic neurons. Peripheral Neuropathy 1993, 1065. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
66. Dyck P., Chance P.F., Lebo R., Carney A. Hereditary motor and sensory neuropathies. Peripheral Neuropathy 1993, 1094. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
67. Dyck P.J., Ellefson R.D., Lais A.C., et al. Histologic and lipid studies of sural nerves in inherited hypertrophic neuropathy: preliminary report of a lipid abnormality in nerve and liver in Dejerine-Sottas disease. Mayo Clin. Proc. 1970, 45:286.
68. Dyck P.J., Karnes J.L., Lambert E.H. Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1. Neurology 1989, 39:1302.
69. Dyck P.J., Lambert E.H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy: II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch. Neurol. 1968, 18:619.
70. Dyck P.J., Lambert E.H., Nichols P.C. Quantitative measurement of sensation related to compound action potentials in health, Friedreich's ataxia, hereditary sensory neuropathy, and tabes dorsalis. Handbook of Electroencephalography and Clinical Neurophysiology 1971, 9:83. Elsevier, Amsterdam. W.A. Cobb (Ed.).
71. Dyck P.J., Litchy W.J., Daube J.R., et al. Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve 2003, 27:202.
72. Dyck P.J., Litchy W.J., Lehman K.A., et al. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of Healthy Subjects [see comment]. Neurology 1995, 45:1115.
73. Dyck P.J., Litchy W.J., Minnerath S., et al. Hereditary motor and sensory neuropathy with diaphragm and vocal cord paresis. Ann. Neurol. 1994, 35:608.
74. Dyck P.J., O'Brien P.C., Litchy W.J., et al. Use of percentiles and normal deviates to express nerve conduction and other test abnormalities. Muscle Nerve 2001, 24:307.
75. Dyck P.J., Oviatt K.F., Lambert E.H. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann. Neurol. 1981, 10:222.
76. Dyck P.J., Sherman W.R., Hallcher L.M., et al. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry. Ann. Neurol. 1980, 8:590.
77. Dyck P.J., Stevens J.C., Mulder D.W., Espinosa R.E. Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis: morphometry of deep and superficial peroneal nerves. Neurology 1975, 25:781.
78. Dyck P.J., Swanson C.J., Low P.A., et al. Prednisone-responsive hereditary motor and sensory neuropathy. Mayo Clin. Proc. 1982, 57:239.
79. Eikelenboom M.J., Petzold A., Lazeron R.H., et al. Multiple sclerosis: neurofilament light chain antibodies are correlated to cerebral atrophy. Neurology 2003, 60:219.
80. Fatkin D., Dodds G.A., Kisslo J., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease [see comment]. Am. J. Cardiol. 1999, 83:13H.
81. Feit H., Silbergleit A., Schneider L.B., et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am. J. Hum. Genet. 1998, 63:1732.
82. Ferguson F.R., Critchley M. Leber's optic atrophy and its relationship with the heredofamilial ataxias. J. Neurol. Psychopathol. 1928, 9:120.
83. Figlewicz D.A., Krizus A., Martinoli M.G., et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994, 3:1757.
84. Filbin M.T., Tennekoon G.I. Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair. J. Cell Biol. 1993, 122:451.
85. Fink J.K. The hereditary spastic paraplegias: nine genes and counting. Arch. Neurol. 2003, 60:1045.
86. Fischbeck K.H., Rushdi N., Pericak-Vance M., et al. X-linked neuropathy: gene localization with DNA probes. Ann. Neurol. 1986, 20:527.
87. Fischbeck K.H., Ritter A., Shi Y., et al. Linkage studies of X-linked neuropathy and spinal muscular atrophy: human gene mapping 9. Cytogenet. Cell Genet. 1987, 46:614.
88. Flanigan K.M., Crawford T.O., Griffin J.W., et al. Localization of the giant axonal neuropathy gene to chromosome 16q24. Ann. Neurol. 1998, 43:143.
89. Fleury P., Hageman G. A dominantly inherited lower motor neuron disorder presenting at birth with associated arthrogryposis. J. Neurol. Neurosurg. Psychiatry 1985, 48:1037.
90. Frei R., Motzing S., Kinkelin I., et al. Loss of distal axons and sensory Merkel cells and features indicative of muscle denervation in hindlimbs of P0-deficient mice. J. Neurosci. 1999, 19:6058.
91. Frequin S.T., Gabreels F.J., Gabreels-Festen A.A., Joosten E.M. Sensory axonopathy in hereditary distal spinal muscular atrophy. Clin. Neurol. Neurosurg. 1991, 93:323.
92. Frith J.A., McLeod J.G., Nicholson G.A., Yang F. Peroneal muscular atrophy with pyramidal tract features (hereditary motor and sensory neuropathy type V): a clinical, neurophysiological, and pathological study of a large kindred. J. Neurol. Neurosurg. Psychiatry 1994, 57:1343.
93. Gambarelli D., Hassoun J., Pellissier J.F., et al. Giant axonal neuropathy: involvement of peripheral nerve, myenteric plexus and extra-neuronal area. Acta Neuropathol. (Berl.) 1977, 39:261.
94. Ge Q., Trieu E.P., Targoff I.N. Primary structure and functional expression of human glycyl-tRNA synthetase, an autoantigen in myositis. J. Biol. Chem. 1994, 269:28790.
95. Grohmann K., Schuelke M., Diers A., et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat. Genet. 2001, 29:75.
96. Grohmann K., Wienker T.F., Saar K., et al. Diaphragmatic spinal muscular atrophy with respiratory distress is heterogeneous, and one form is linked to chromosome 11q13-q21. Am. J. Hum. Genet. 1999, 65:1459.
97. Hahn A.F., Ainsworth P.J., Bolton C.F., et al. Pathological findings in the X-linked form of Charcot-Marie-Tooth disease: a morphometric and ultrastructural analysis. Acta Neuropathol. (Berl.) 2001, 101:129.
98. Hahn A.F., Bolton C.F., White C.M., et al. Genotype/phenotype correlations in X-linked dominant Charcot-Marie-Tooth disease. Ann. N. Y. Acad. Sci. 1999, 883:366.
99. Hanemann C.O., Bergmann C., Senderek J., et al. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch. Neurol. 2003, 60:605.
100. Hanemann C.O., Gabreels-Festen A.A., De Jonghe P. Axon damage in CMT due to mutation in myelin protein P0. Neuromuscul. Disord. 2001, 11:753. [Erratum appears in Neuromuscul. Disord. 12: 432, 2002.].
101. Harding A.E. Inherited neuronal atrophy and degeneration predominantly of the lower motor neurons. Peripheral Neuropathy 1993, 1051. W. B. Saunders, Philadelphia. 3rd ed. P.J. Dyck, P.K. Thomas, J.W. Griffin (Eds.).
102. Harrison R.E., Bucci C., Vieira O.V., et al. Phagosomes fuse with late endosomes and/or lysosomes by extension of membrane protrusions along microtubules: role of Rab7 and RILP. Mol. Cell. Biol. 2003, 23:6494.
103. Hayasaka K., Nanao K., Tahara M., et al. Isolation and sequence determination of cDNA encoding the major structural protein of human peripheral myelin. Biochem. Biophys. Res. Commun. 1991, 180:515.
104. Hayasaka K., Ohnishi A., Takada G., et al. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1. Biochem. Biophys. Res. Commun. 1993, 194:1317.
105. Head H. Peroneal atrophy. Proc. R. Soc. Med. 1913, 6:51.
106. Higgins J.J., Kluetzman K., Berciano J., et al. Posterior column ataxia and retinitis pigmentosa: a distinct clinical and genetic disorder. Mov. Disord. 2000, 15:575.
107. Higgins J.J., Morton D.H., Patronas N., Nee L.E. An autosomal recessive disorder with posterior column ataxia and retinitis pigmentosa [see comment]. Neurology 1997, 49:1717.
108. Howard H.C., Mount D.B., Rochefort D., et al. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum. Nat. Genet. 2002, 32:384.
109. Hoyt W.F. Charcot-Marie-Tooth disease with primary optic atrophy. Arch. Ophthalmol. 1960, 64:935.
110. Igisu H., Ohta M., Tabira T., et al. Giant axonal neuropathy: a clinical entity affecting the central as well as the peripheral nervous system. Neurology 1975, 25:717.
111. Inamdar K.V., Pouliot J.J., Zhou T., et al. Conversion of phosphoglycolate to phosphate termini on 3 overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1. J. Biol. Chem. 2002, 277:27162.
112. Ionasescu V., Ionasescu R., Searby C. Correlation between connexin 32 gene mutations and clinical phenotype in X-linked dominant Charcot-Marie-Tooth neuropathy. Am. J. Med. Genet. 1996, 63:486.
113. Ionasescu V., Searby C., Sheffield V.C., et al. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D). Hum. Mol. Genet. 1996, 5:1373.
114. Ionasescu V.V., Trofatter J., Haines J.L., et al. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy. Am. J. Hum. Genet. 1991, 48:1075.
115. Ionasescu V.V., Trofatter J., Haines J.L., et al. X-linked recessive Charcot-Marie-Tooth neuropathy: clinical and genetic study. Muscle Nerve 1992, 15:368.
116. Ismailov S.M., Fedotov V.P., Dadali E.L., et al. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21. Eur. J. Hum. Genet. 2001, 9:646.
117. Isozaki E., Naito R., Kanda T., et al. Different mechanism of vocal cord paralysis between spinocerebellar ataxia (SCA 1 and SCA 3) and multiple system atrophy. J. Neurol. Sci. 2002, 197:37.
118. Janota I. Neuroaxonal dystrophy in the neonate: a case report. Acta Neuropathol. (Berl.) 1979, 46:151.
119. Jedrzejowska H., Drac H. Infantile chronic peripheral neuropathy with giant axons. Acta Neuropathol. (Berl.) 1977, 37:213.
120. Jones S.M., Howell K.E., Henley J.R., et al. Role of dynamin in the formation of transport vesicles from the trans-Golgi network. Science 1998, 279:573.
121. Jordanova A., de Jong P., Boerkoel C.F., et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003, 126:590.
122. Jordens I., Fernandez-Borja M., Marsman M., et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr. Biol. 2001, 11:1680.
123. Julien J.P., Grosveld F., Yazdanbaksh K., et al. The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family. Biochim. Biophys. Acta 1987, 909:10.
124. Khoubesserian P., Van Regemarter N., Ohrn-Degueldre O., et al. Charcot-Marie-Tooth disease with retinal pigment dystrophy and protanopia. J. Neurol. 1979, 221:1.
125. Klein C.J., Cunningham J.M., Atkinson E.J., et al. The gene for hereditary motor and sensory neuropathy type 2C maps to 12q24. Ann. Neurol. 2002, 52:S47.
126. Klein C.J., Cunningham J.M., Atkinson E.J., et al. The gene for HMSN2C maps to 12q23-24: a region of neuro-muscular disorders. Neurology 2003, 60:1151.
127. Kleopa K.A., Scherer S.S. Inherited neuropathies. Neurol. Clin. 2002, 20:679.
128. Kuhlenbaumer G., Young P., Oberwittler C., et al. Giant axonal neuropathy (GAN): case report and two novel mutations in the gigaxonin gene [see comment]. Neurology 2002, 58:1273. [erratum appears in Neurology 58: 1444, 2002.].
129. Kuntzer T., Dunand M., Schorderet D.F., et al. Phenotypic expression of a Pro 87 to Leu mutation in the connexin 32 gene in a large Swiss family with Charcot-Marie-Tooth neuropathy. J. Neurol. Sci. 2003, 207:77.
130. Kurihara S., Adachi Y., Wada K., et al. An epidemiological genetic study of Charcot-Marie-Tooth disease in Western Japan. Neuroepidemiology 2002, 21:246.
131. Kwon J.M., Elliott J.L., Yee W.C., et al. Assignment of a second Charcot-Marie-Tooth type II locus to chromosome 3q. Am. J. Hum. Genet. 1995, 57:853.
132. Lai C., Brow M.A., Nave K.A., et al. Two forms of 1B236/myelin-associated glycoprotein, a cell adhesion molecule for postnatal neural development, are produced by alternative splicing. Proc. Natl. Acad. Sci. U. S. A. 1987, 84:4337.
133. Laporte J., Hu L.J., Kretz C., et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 1996, 13:175.
134. Lemke G., Axel R. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 1985, 40:501.
135. Lewis R.A., Sumner A.J. Electrophysiologic features of inherited demyelinating neuropathies: a reappraisal. Ann. N. Y. Acad. Sci. 1999, 883:321.
136. Lewis R.S., Sumner A.J., Shy M.E. Inherited neuropathies. Neuromuscular Function and Disease 2002, 1017. W. B. Saunders, Philadelphia. W.F. Brown, C.F. Bolton, M.J. Aminoff (Eds.).
137. Lus G., Nelis E., Jordanova A., et al. Charcot-Marie-Tooth disease with giant axons: a clinicopathological and genetic entity. Neurology 2003, 61:988.
138. Marques W., Sweeney J.G., Wood N.W., et al. Central nervous system involvement in a novel connexin 32 mutation affecting identical twins. J. Neurol. Neurosurg. Psychiatry 1999, 66:803.
139. Marrosu M.G., Vaccargiu S., Marrosu G., et al. Charcot-Marie-Tooth disease type 2 associated with mutation of the myelin protein zero gene. Neurology 1998, 50:1397.
140. Massion-Verniory M.P., Dumont E., Potvin A.M. Retinite pigmentaire familiale complique ďune amyotrophie neurale. Rev. Neurol. (Paris) 1946, 78:561.
141. Mastaglia F.L., Nowak K.J., Stell R., et al. Novel mutation in the myelin protein zero gene in a family with intermediate hereditary motor and sensory neuropathy. J. Neurol. Neurosurg. Psychiatry 1999, 67:174.
142. McEntagart M., Norton N., Williams H., et al. Localization of the gene for distal hereditary motor neuronopathy VII (dHMN-VII) to chromosome 2q14. Am. J. Hum. Genet. 2001, 68:1270.
143. McKusick V. Mendelian Inheritance in Man 1998, Johns Hopkins University Press, Baltimore, Available atwww3.ncbi.nlm.nih.gov/Omim.
144. McLeod J.G., Low P.A., Morgan J.A. A family with Charcot-Marie-Tooth disease and Leber's optic atrophy. Proc. Aust. Assoc. Neurol. 1975, 12:23.
145. Mersiyanova I.V., Perepelov A.V., Polyakov A.V., et al. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am. J. Hum. Genet. 2000, 67:37.
146. Milhorat A.T. Studies in diseases of muscles: XIV. Progressive muscular atrophy of the optic nerves: report on a family. Arch. Neurol. 1943, 50:279.
147. Misu K., Yoshihara T., Shikama Y., et al. An axonal form of Charcot-Marie-Tooth disease showing distinctive features in association with mutations in the peripheral myelin protein zero gene (Thr124Met or Asp75Val). J. Neurol. Neurosurg. Psychiatry 2000, 69:806.
148. Misu K., Yoshihara T., Yamamoto M., et al. Two families of Charcot-Marie-Tooth disease with Adie's pupil, axonal neuropathy and the Thr124Met mutation in the peripheral myelin protein zero gene. Rinsho Shinkeigaku 2000, 40:149.
149. Mizuno Y., OtsGBRa S., Takano Y., et al. Giant axonal neuropathy: combined central and peripheral nervous system disease. Arch. Neurol. 1979, 36:107.
150. Muchir A., Bonne G., Kooi A.J., et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum. Mol. Genet. 2000, 9:1453.
151. Muglia M., Magariello A., Nicoletti G., et al. A large family with pure autosomal dominant hereditary spastic paraplegia from southern Italy mapping to chromosome 14q11.2-q24.3. J. Neurol. 2002, 249:1413.
152. Muglia M., Zappia M., Timmerman V., et al. Clinical and genetic study of a large Charcot-Marie-Tooth type 2A family from southern Italy. Neurology 2001, 56:100.
153. Nagamatsu M., Jenkins R.B., Schaid D.J., et al. Hereditary motor and sensory neuropathy type 2C is genetically distinct from types 2B and 2D. Arch. Neurol. 2000, 57:669.
154. Nakagawa M., Takashima H., Umehara F., et al. Clinical phenotype in X-linked Charcot-Marie-Tooth disease with an entire deletion of the connexin 32 coding sequence. J. Neurol. Sci. 2001, 185:31.
155. Nelis E., Erdem S., Bergh P.Y., et al. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy [see comment]. Neurology 2002, 59:1865.
156. Nelis E., Haites N., Van Broeckhoven C. Mutations in the peripheral myelin genes and associated genes in inherited peripheral neuropathies. Hum. Mutat. 1999, 13:11.
157. Nicoziani P., Vilhardt F., Llorente A., et al. Role for dynamin in late endosome dynamics and trafficking of the cation-independent mannose 6-phosphate receptor. Mol. Biol. Cell 2000, 11:481.
158. Novelli G., Muchir A., Sangiuolo F., et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am. J. Hum. Genet. 2002, 71:426.
159. Numakura C., Lin C., Ikegami T., et al. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations. Hum. Mutat. 2002, 20:392.
160. Ochoa G.C., Slepnev V.I., Neff L., et al. A functional link between dynamin and the actin cytoskeleton at podosomes. J. Cell Biol. 2000, 150:377.
161. Omran H., Ketelsen U.P., Heinen F., et al. Axonal neuropathy and predominance of type II myofibers in infantile spinal muscular atrophy. J. Child Neurol. 1998, 13:327.
162. Othmane K.B., Middleton L.T., Loprest L.J., et al. Localization of a gene (CMT 2A) for autosomal dominant Charcot-Marie-Tooth disease, type 2 to chromosome 1p and evidence of genetic heterogeneity. Genomics 1993, 17:370.
163. Ouvrier R.A., Prineas J., Walsh J.C., et al. Giant axonal neuropathy-a third case. Proc. Aust. Assoc. Neurol. 1974, 11:137.
164. Panas M. Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations [see comment]. J. Neurol. Neurosurg. Psychiatry 1998, 65:947.
165. Peiffer J., Schlote W., Bischoff A., et al. Generalized giant axonal neuropathy: a filament-forming disease of neuronal, endothelial, glial, and Schwann cells in a patient without kinky hair. Acta Neuropathol. (Berl.) 1977, 40:213.
166. Perez-Garrigues H., Burguera J.A., Lopez Arlandis Gea A. Laryngeal stridor caused by Gerhardt's syndrome in olivopontocerebellar atrophy and a probable striatonigral degeneration [in Spanish]. An. Otorrinolaringol. Ibero Am. 1990, 17:5.
167. Pericak-Vance M.A., Speer M.C., Lennon F., et al. Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics 1997, 1:89.
168. Pierce T., Worman H.J., Holy J. Neuronal differentiation of NT2/D1 teratocarcinoma cells is accompanied by a loss of lamin A/C expression and an increase in lamin B1 expression. Exp. Neurol. 1999, 157:241.
169. Pitts K.R., Yoon Y., Krueger E.W., McNiven M.A. The dynamin-like protein DLP1 is essential for normal distribution and morphology of the endoplasmic reticulum and mitochondria in mammalian cells. Mol. Biol. Cell 1999, 10:4403.
170. Poliak S., Gollan L., Salomon D., et al. Localization of Caspr2 in myelinated nerves depends on axon-glia interactions and the generation of barriers along the axon. J. Neurosci. 2001, 21:7568.
171. Pouliot J.J., Yao K.C., Robertson C.A., Nash H.A. Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 1999, 286:552.
172. Prineas J.W., Ouvrier R.A., Wright R.G., et al. Giant axonal neuropathy-a generalized disorder of cytoplasmic microfilament formation. J. Neuropathol. Exp. Neurol. 1976, 35:458.
173. Puls I., Jonnakuty C., LaMonte B.H., et al. Mutant dynactin in motor neuron disease. Nat. Genet. 2003, 33:455.
174. Raffaeledi Barletta M., Ricci E., Galluzzi G., et al. Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 2000, 66:1407.
175. Rainier S., Jones S.M., Esposito C., et al. Analysis of microtubule-associated protein 1a gene in hereditary spastic paraplegia. Neurology 1998, 51:1509.
176. Reid E., Kloss M., Ashley-Koch A., et al. A kinesin heavy dhan (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. 2002, 71:1189.
177. Ressot C., Bruzzone R. Connexin channels in Schwann cells and the development of the X-linked form of Charcot-Marie-Tooth disease. Brain Res. Brain Res. Rev. 2000, 32:192.
178. Rozental R., Giaume C., Spray D.C. Gap junctions in the nervous system. Brain Res. Brain Res. Rev. 2000, 32:11.
179. Sahenk Z., Chen L. Abnormalities in the axonal cytoskeleton induced by a connexin32 mutation in nerve xenografts. J. Neurosci. Res. 1998, 51:174.
180. Saito M., Hayashi Y., SuzGBRi T., et al. Linkage mapping of the gene for Charcot-Marie-Tooth disease type 2 to chromosome 1p (CMT2A) and the clinical features of CMT2A. Neurology 1997, 49:1630.
181. Sambuughin N., Sivakumar K., Selenge B., et al. Autosomal dominant distal spinal muscular atrophy type V (dSMA-V) and Charcot-Marie Tooth disease type 2D (CMT2D) segregate within a single large kindred and map to a refined region on chromosome 7P15. J. Neurol. Sci. 1998, 161:23.
182. Sancho S., Magyar J.P., Aguzzi A., Suter U. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999, 122:1563.
183. Santoro L., Manganelli F., Maio L., et al. CMT2C: A distinct genetic entity. Description of the first European family. Neuromuscul. Disord. 2002, 12:399.
184. Sarnat H.B., Roth S.I., Jimenez J.F. Neonatal myotubular myopathy: neuropathy and failure of postnatal maturation of fetal muscle. Can. J. Neurol. Sci. 1981, 8:313.
185. Schelhaas H.J., Van Engelen B.G., Gabreels-Festen A.A., et al. Transient cerebral white matter lesions in a patient with connexin 32 missense mutation. Neurology 2002, 59:2007.
186. Scherer S.S., Arroyo E.J. Recent progress on the molecular organization
187. Scherer S.S., Salaer J.L. Axon-Schwann cell interactions in peripheral nerve regeneration. Glial Cell Development 1996, 299. Oxford University Press, Oxford, GBR. K.R. Jessen, W.D. Richardson (Eds.).
188. Schiavon F., Rampazzo A., Merlini L., et al. Mutations of the same sequence of the myelin P0 gene causing two different phenotypes. Hum. Mutat. Suppl 1998, 1:S217.
189. Schmid C.D., Stienekemeier M., Oehen S., et al. Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance. J. Neurosci. 2000, 20:729.
190. Seemann P., Huehne K., Rautenstrauss B., et al. An axonal form of Charcot-Marie-Tooth disease beginning with deafness and abnormal pupillar reaction: new mutation in the myelin protein zero gene (MPZ) in a Czech family. Nervenheilkunde 2001, 20:S28.
191. Seitelberger, F.: Eine unbekannte Form von invantiler lipoidspeicher Krankheit des Gehirns. In Proceedings of the First International Congress of Neuropathology, Vol. 3. Turin, Rosenberg and Sellier, p. 323, 1952.
192. Senderek J., Bergmann C., Ramaekers V.T., et al. Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy. Brain 2003, 126:642.
193. Senderek J., Hermanns B., Lehmann U., et al. Charcot-Marie-Tooth neuropathy type 2 and P0 point mutations: two novel amino acid substitutions (Asp61Gly; Tyr119Cys) and a possible "hotspot" on Thr124Met. Brain Pathol. 2000, 10:235.
194. Seven M., Ozkilic A., YGBRsel A. Dysmorphic face in two siblings with infantile neuroaxonal dystrophy. Genet. Couns. 2002, 13:465.
195. Sevilla T., Cuesta A., Chumillas M.J., et al. Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene. Brain 2003, 126:2023.
196. Shackleton S. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy [see comment]. Nat. Genet. 2000, 24:153.
197. Shapiro L., Doyle J.P., Hensley P., et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996, 17:435.
198. Shen M.R., Chou C.Y., Hsu K.F., et al. The KCl cotransporter isoform KCC3 can play an important role in cell growth regulation. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14714.
199. Shiojiri T., Tsunemi T., Matsunaga T., et al. Vocal cord abductor paralysis in spinocerebellar ataxia type 1. J. Neurol. Neurosurg. Psychiatry 1999, 67:695.
200. Shorer Z., Philpot J., Muntoni F., et al. Demyelinating peripheral neuropathy in merosin-deficient congenital muscular dystrophy. J. Child Neurol. 1995, 10:472.
201. Silver J.R. Spastic paraplegia with amyotrophy of the hands. J. Neurol. Neurosurg. Psychiatry 1966, 29:135.
202. Stojkovic T., Latour P., Vandenberghe A., et al. Sensorineural deafness in X-linked Charcot-Marie-Tooth disease with connexin 32 mutation (R142Q). Neurology 1999, 52:1010. [Erratum appears in Neurology,. 52, 1952 1999.].
203. Stuurman N., Heins S., Aebi U. Nuclear lamins: their structure, assembly, and interactions. J. Struct. Biol. 1998, 122:42.
204. Sullivan T., Escanlant-Alcade D., Bhatt H., et al. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J. Cell Biol. 1999, 147:913.
205. Takashima H., Boerkoel C.F., John J., et al. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 2002, 32:267.
206. Takashima H., Nakagawa M., Nakahara K., et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann. Neurol. 1997, 41:771.
207. Takashima H., Suehara M., Saito M., et al. Gene for hereditary motor and sensory neuropathy (proximal dominant form) mapped to 3q13.1. Ann. N. Y. Acad. Sci. 1999, 883:449.
208. Targoff I.N. Update on myositis-specific and myositis-associated autoantibodies. Curr. Opin. Rheumatol. 2000, 12:475.
209. Taylor J. Peroneal atrophy. Proc R. Soc. Med. 1913, 6:50.
210. Teunissen L.L., Notermans N.C., Franssen H., et al. Disease course of Charcot-Marie-Tooth disease type 2: a 5-year follow-up study. Arch. Neurol. 2003, 60:823.
211. Tomkins J., Usher P., Slade P., et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport 1998, 9:3967.
212. Verhelst H.E., Lofgren A., Van Coster R.N. A family with X-linked dominant Charcot-Marie-Tooth caused by a connexin32 mutation. Eur. J. Paediatr. Neurol. 2000, 4:235.
213. Verhoeven K., De Jonghe P., Coen K., et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am. J. Hum. Genet. 2003, 72:722.
214. Vieira O.V., Bucci C., Harrison R.E., et al. Modulation of Rab5 and Rab7 recruitment to phagosomes by phosphatidyli-nositol 3-kinase. Mol. Cell. Biol. 2003, 23:2501.
215. Vizioli: Dell'atrofia progr. nervosa. Boll. R. Acad. Medico-chir Napoli, 1889.
216. Vogel P., Gabriel M., Goebel H.H., Dyck P.J. Hereditary motor sensory neuropathy type II with neuro-filament accumulation: new finding or new disorder? Ann. Neurol. 1985, 17:455-461.
217. Vogler O., Bogatkewitsch G.S., Wriske C., et al. Receptor subtype-specific regulation of muscarinic acetylcholine receptor sequestration by dynamin: distinct sequestration of m2 receptors. J. Biol. Chem. 1998, 273:12155-12160.
218. Wilson S.A.K. Neurology 1940, 1:219. Edward Arnold, London. A.N. Bruce (Ed.).
219. Wisniewski K., Wisniewski H.M. Diagnosis of infantile neuroaxonal dystrophy by skin biopsy. Ann. Neurol. 1980, 7:377.
220. Witt T.N., Garner C.G., Pongratz D., Baur X. Autosomal dominant Emery-Dreifuss syndrome: evidence of a neurogenic variant of the disease. Eur. Arch. Psychiatry Neurol. Sci. 1988, 237:230.
221. Wong M.H., Filbin M.T. Dominant-negative effect on adhesion by myelin P0 protein truncated in its cytoplasmic domain. J. Cell Biol. 1996, 134:1531.
222. Yan W.X., Archelos J.J., Hartung H.P., Pollard J.D. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann. Neurol. 2001, 50:286.
223. Young P., Grote K., Kuhlenbaumer G., et al. Mutation analysis in Chariot-Marie Tooth disease type 1: point mutations in the MPZ gene and the GJB1 gene cause comparable phenotypic heterogeneity. J. Neurol. 2001, 248:410.
224. Zhang K., Filbin M.T. Myelin P0 protein mutated at Cys21 has a dominant-negative effect on adhesion of wild type P0. J. Neurosci. Res. 1998, 53:1.
225. Zhao C., Takita J., Tanaka Y., et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001, 105:587.
226. Zhao X., Alvarado D., Rainier S., et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat. Genet. 2001, 29:326.
227. Zhu Q., Couillard-Despres S., Julien J.P. Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp. Neurol. 1997, 148:299.